(KMPH) - Earnings & Price History

KMPH: - 3.7085, $56.71M, -0.09 (-2.41%)

Sector: Healthcare - Industry: Biotechnology

KemPharm, Inc., a clinical-stage specialty pharmaceutical company, discovers and develops new proprietary prodrugs in the United States. Its advanced product candidate is KP201/APAP, which consists of KP201 prodrug of hydrocodone formulated in combination with acetaminophen (APAP). The company is also developing KP201/APAP as an immediate release (IR) product candidate for the treatment of acute pain, as well as engages in designing KP201/APAP with abuse-deterrent properties to address the epidemic of opioid abuse. The company is also involved in developing KP201/IR (APAP-free), an IR formulation of KP201 without APAP for the short-term management of acute pain; KP511/ER, a prodrug of hydromorphone for the management of pain; KP415, a prodrug of methylphenidate for the treatment of attention deficit hyperactivity disorders; KP606/IR, an IR abuse-deterrent opioid product for the managemen

Past KMPH reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-09AMC-0.73.953.553.553.5411.27%11.27%36.46K
2016-11-09AMC-0.634.14.053.93.854.2-3.70%▲5.13%1.23%96.09K
2016-08-10AMC-0.7543.783.973.724.025.03%0.76%5.82%63.97K
2016-05-12AMC-0.466.026.616.885.896.964.08%-12.50%-8.93%623.86K
2016-03-10AMC-0.514.0513.8714.1913.8614.512.31%-0.99%1.30%63.65K

Login | Register
Friday Nov 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades